Skip to main content
. 2017 Nov 9;15:93. doi: 10.1186/s12961-017-0259-8

Table 2.

Complications noted and use of antibiotics in influenza-infected patients

Trial Southern Hemisphere (NAIB3001) Europe (NAIB3002) North America (NAIA3002)
Complications
Placebo 30% 33% 22%
Zanamivir 24% 24% 15%
P value 0.24 0.125 0.049*
Antibiotics use
Placebo 28% 17% 15%
Zanamivir 26% 11% 11%
P value 0.58 0.21 0.16

*P < 0.05